Endeavour Silver Corp. (NYSE:EXK) is up 1.5% in pre-market trade on Monday as it provided updated NI 43-101 silver and gold reserve and resource estimates for its three producing silver mines in Mexico (the Guanacevi Mine in Durango State and the Bolanitos and El Cubo Mines in Guanajuato State) as well as one exploration project (San Sebastian Project in Jalisco State) as of December 31, … Continue reading Pre-Market Movers – EXK, LLY, DDS, TGE, CPS
Thursday, after the markets closed, Healthways reported somewhat noisy fourth-quarter results, given an accounting change that required the deferral of roughly $10 million in sales/profits into future periods. Importantly, the company provided services and incurred all the costs related to this revenue stream, received the entire $10 million in cash during the quarter, and maintains an ongoing relationship with the client; it simply determined that, … Continue reading Healthways, Inc. Double-Digit Organic Growth on the Horizon
SS&C reported healthy fourth-quarter results that were roughly in line with expectations on the top line but above expectations on the bottom line. The company delivered revenue of $182.5 million (growth of 6.3% year-over-year), slightly below consensus at $182.6 million, and non-GAAP EPS of $0.53, which was a penny ahead of the Street ($0.52). The software-enabled services and software license segments continue to benefit from … Continue reading SS&C Technologies Report Healthy Fourth-Quarter Results
On Monday, February 10, Blount issued a broad press release lowering its 2013 guidance and offering 2014 guidance that was below the Street expectations. Management held a conference call Tuesday afternoon to explain the results and outlook. Other corporate information was offered as well, including new 2018 targets and an update on the company’s long-term supply agreement with Husqvarna (extended from 2015 to 2017). Blount … Continue reading Blount Conference Call Clarifies a Few Issues; 2014 Now Looks Like a Transition Year
For fourth quarter 2013, BroadSoft should meet or beat consensus estimates. We expect a large chunk of deferred revenue to come off the balance sheet and billings to show significant improvement sequentially in virtually all areas license, subscription, and maintenance on easy comparisons with the exception of professional services, which rebounded sharply in the third quarter. With respect to the outlook, the swing factor in … Continue reading Broadsoft Expected to Report Strong Quarter; Sprint Bringing Credibility in Mobile
PacBio reported results that were in line with our expectations but slightly ahead of consensus. Revenue was $9.1 million, relative to our estimate of $9.8 million and consensus of $8.8 million, and loss per share was $0.26, relative to our estimate and consensus of loss per share of $0.28. The company booked orders for 9 PacBio RS systems in the quarter (versus our estimate of … Continue reading Pacific Biosciences Posts Encouraging Quarterly Results
